Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease

F Conrotto, S Salizzoni, A Andreis, F D'Ascenzo, A D'Onofrio, M Agrifoglio, A Chieffo, A Colombo, F Rapetto, F Santini, G Tarantini, D Gabbieri, C Savini, S Immè, F Ribichini, O Valsecchi, M Aiello, G Lixi, A Iadanza, E PompeiM Stolcova, D Ornaghi, A Minati, M Cassese, GL Martinelli, P Sbarra, A Agostinelli, A Audo, A Pieroni, R Fiorilli, G Gerosa, M Rinaldi, F Gaita

Research output: Contribution to journalArticlepeer-review


Advanced chronic kidney disease (CKD) is associated with poor outcomes in patients who underwent surgical aortic valve replacement, whereas its prognostic role in transcatheter aortic valve implantation (TAVI) remains unclear. This study aimed to investigate outcomes in patients with advanced CKD who underwent TAVI. A total of 1,904 consecutive patients who underwent balloon-expandable TAVI in 33 centers between 2007 and 2012 were enrolled in the Italian Transcatheter Balloon-Expandable Valve Implantation Registry. Advanced CKD was defined according to the estimated glomerular filtration rate: 15 to 29 ml/min/1.73 m2 stage 4 (S4),
Original languageEnglish
Pages (from-to)1438-1442
Number of pages5
JournalAmerican Journal of Cardiology
Issue number9
Publication statusPublished - 2017


Dive into the research topics of 'Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease'. Together they form a unique fingerprint.

Cite this